Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 6, 1996, Pages 1155-1164

  Barclay, Murray L ^a   Begg, Evan J ^a   Chambers, Stephen T ^a   Thornley, Peter E ^a   Pattemore, Philip K ^a   Grimwood, Keith ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; TOBRAMYCIN;

ADAPTATION; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG SPUTUM LEVEL; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG INFECTION; MALE; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SPUTUM; TIME;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CYSTIC FIBROSIS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; LUNG DISEASES; MALE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM; TIME FACTORS; TOBRAMYCIN;

EID: 0029781290     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.6.1155     Document Type: Article

References (36)

1. Barclay, M. L., Begg, E. J. & Chambers, S. T. (1992). Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrobial Agents and Chemotherapy 36, 1951-7.
2. Barclay, M. L., Begg, E. J. & Hickling, K. G. (1994). What is the evidence for once-daily aminoglycoside therapy? Clinical Pharmacokinetics 27, 32-48.
3. Bataillon, V., Lhermitte, M., Lafitte, J.-J., Pommery, J. & Roussel, P. (1992). The binding of amikacin to macromolecules from the sputum of patients suffering from respiratory diseases. Journal of Antimicrobial Chemotherapy 29, 499-508.
4. Carswell, F., Ward, C., Cook, D. A. & Speller, D. C. (1987). A controlled trial of nebulized aminoglycoside and oral flucloxacillin versus placebo in the outpatient management of children with cystic fibrosis. British Journal of Diseases of the Chest 81, 356-60.
5. Cooney, G. F., Lum, B. L., Tomaselli, M. & Fiel, S. B. (1994). Absolute bioavailability and absorption characteristics of aerosolized tobramycin in adults with cystic fibrosis. Journal of Clinical Pharmacology 34, 255-9.
6. Daikos, G. L., Jackson, G. G., Lolans, V. T. & Livermore, D. M. (1990). Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. Journal of Infectious Diseases 162, 414-20.
7. Daikos, G. L., Lolans, V. T. & Jackson, G. G. (1991). First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrobial Agents and Chemotherapy 35, 117-23.
8. Davis, S. D. & Bruns, W. T. (1978). Effects of sputum from patients with cystic fibrosis on the activity in vitro of 5 antimicrobial drugs on Pseudomonas aeruginosa. American Reviews of Respiratory Disease 117, 176-8.
9. Gappa, M., Steinkamp, G., Tümmler, B. & von der Hardt, H. (1988). Long-term tobramycin therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Scandinavian Journal of Gastroenterology, Suppl. 143, 74-6.
10. Gilbert, P., Collier, P. J. & Brown, M. R. W. (1990). Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrobial Agents and Chemotherapy 34, 1865-8.
11. Gilleland, H. E. (1988). Adaptive alterations in the outer membrane of Gram-negative bacteria during human infection. Canadian Journal of Microbiology 34, 499-502.
12. Gilleland, L. B., Gilleland, H. E., Gibson, J. A. & Champlin, F. R. (1989). Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa. Journal of Medical Microbiology 29, 41-50.
13. Gould, I. M., Milne, K., Harvey, G. & Jason, C. (1991). Ionic binding, adaptive resistance and post-antibiotic effect of netilmicin and ciprofloxacin. Journal of Antimicrobial Chemotherapy 27, 741-8.
14. Grimwood, K., Semple, R. A., Rabin, H. R., Sokol, P. A. & Woods, D. E. (1993). Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatric Pulmonology 15, 135-9.
15. Grimwood, K., To, M., Rabin, H. R. & Woods, D. E. (1989a). Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations. Antimicrobial Agents and Chemotherapy 33, 41-7.
16. Grimwood, K., To, M., Rabin, H. R. & Woods, D. E. (1989b). Subinhibitory antibiotics reduce Pseudomonas aeruginosa tissue injury in the rat model. Journal of Antimicrobial Chemotherapy 24, 937-45.
17. Grothues, D. & Tümmler, B. (1991). New approaches in genome analysis by pulsed-field gel electrophoresis: application to the analysis of Pseudomonas species. Molecular Microbiology 5, 2763-76.
18. Heininger, U., Bowing, B., Stehr, K. & Solbach, W. (1993). Aminoglycosides in patients with mucoviscidosis and pulmonary exacerbation. Comparison of once or three times daily administration. Klinische Padiatrie 205, 18-22.
19. Hjelte, L., Malmborg, A.-S. & Strandvik, B. (1989). Serum and sputum concentrations of netilmicin in combination with acylureidopenicillin and cephalosporins in clinical treatment of pulmonary exacerbations in cystic fibrosis. Journal of Antimicrobial Chemotherapy 23, 885-90.
20. Hodson, M. E., Penketh, A. R. L. & Batten, J. C. (1981). Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet ii, 1137-9.
21. Horrevorts, A. M., Driessen, O. M. J., Michel, M. F. & Kerrebijn, K. F. (1988). Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics. Chest 94, Suppl. 2, 120-5.
22. Ilowite, J. S., Gorvoy, J. D. & Smaldone, G. C. (1987), Quantitative deposition of aerosolized gentamicin in cystic fibrosis. American Reviews of Respiratory Disease 136, 1445-9.
23. Karlowsky, J. A., Zhanel, G. G., Davidson, R. J. & Hoban, D. J. (1994). Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 38, 1165-8.
24. Kun, P., Landau, L. I. & Phelan, P. D. (1984). Nebulized gentamicin in children and adolescents with cystic fibrosis. Australian Paediatric Journal 20, 43-5.
25. Levy, J., Smith, A. L., Kenny, M. A., Ramsey, B. & Schoenknecht, F. D. (1983). Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum. Journal of Infectious Diseases 148, 1069-76.
26. Lindsay, C. A. & Bosso, J. A. (1993). Optimisation of antibiotic therapy in cystic fibrosis patients. Clinical Pharmacokinetics 24, 496-506.
27. MacLusky, I. B., Gold, R., Corey, M. & Levison, H. (1989). Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatric Pulmonology 7, 42-8.
28. Mendelman, P. M., Smith, A. L., Levy, J., Weber, A., Ramsey, B. & Davis, R. L. (1985). Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. American Reviews of Respiratory Disease 132, 761-5.
29. Powell, S. H., Thompson, W. L., Luthe, M. A., Stern, R. C., Grossniklaus, D. A., Bloxham, D. D. et al. (1983). Once-daily vs continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin and tobramycin. Journal of Infectious Diseases 147, 918-32.
30. Ramphal, R., Lhermitte, M., Filliat, M. & Roussel, P. (1988). The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum. Journal of Antimicrobial Chemotherapy 22, 483-90.
31. Ramsey, B. W., Dorkin, H. L., Eisenberg, J. D., Gibson, R. L., Harwood, I. R., Kravitz R. et al. (1993). Efficacy of aerosolized tobramycin in patients with cystic fibrosis. New England Journal of Medicine 328, 1740-6.
32. Schaad, U. B., Wedgwood-Krucko, J., Suter, S. & Kraemer, R. (1987). Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis. Journal of Pediatrics 111, 599-605.
33. Stead, R. J., Hodson, M. E. & Batten, J. C. (1987). Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa. British Journal of Diseases of the Chest 81, 272-9.
34. Steinkamp, G., Tümmler, B., Gappa, M., Albus, A., Potel, J., Doring, G. et al. (1989). Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatric Pulmonology 6, 91-8.
35. Wall, M. A., Terry, A. B., Eisenberg, J., McNamara, M. & Cohen, R. (1983). Inhaled antibiotics in cystic fibrosis. Lancet i, 1325.
36. Zach, M. S. (1988). Antibiotic treatment: aerosol therapy. (Discussion). Chest 94, Suppl. 2, 160-1.